Some investors asked on the investor interaction platform: are the ritonavir intermediates of the company’s subsidiaries exported to Europe, America and India?
Jinghua Pharmaceutical Group Co.Ltd(002349) (002349. SZ) said on the investor interaction platform on January 11 that senxuan pharmaceutical, a subsidiary of the company, had been conducive to the export of tonavir intermediates to India and had no relevant business in the near future.
(source: Daily Economic News)
